Skip to main content
Top
Published in: Journal of Cancer Education 3/2011

01-09-2011

The State of Cancer Epidemiology Curricula in Postgraduate Schools Worldwide

Authors: Alireza Mosavi-Jarrahi, Ezanollah Azargashb, Yasaman Mousavi-Jarrahi, Mohammad Ali Mohagheghi

Published in: Journal of Cancer Education | Issue 3/2011

Login to get access

Abstract

The study aimed to describe the cancer epidemiology curricula in postgraduate schools worldwide. Using a stepwise approach, information on the cancer epidemiology curricula were abstracted through an internet search of medical or public heath schools worldwide. The common scientific outline (a scholarly developed classification of cancer-related topics) was used to describe the extents that cancer epidemiology and its scientific domains are incorporated into postgraduate degrees in the epidemiology. Among the 120 studied schools, no school offered an explicitly doctoral degree in cancer epidemiology. Just eight schools offered cancer epidemiology as an area of concentration in their epidemiology curricula. The contents of the cancer epidemiology courses offered in different schools were related in 44% of times to topics of cancer control, 19% times to risk factors, and just 11% of times to biology of cancer. The need for comprehensive re-evaluation of the cancer epidemiology curricula in postgraduate teaching was concluded.
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRef Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRef
2.
go back to reference Twombly R (2005) Cancer surpasses heart disease as leading cause of death for all but the very elderly. J Natl Cancer Inst 97:330–331PubMed Twombly R (2005) Cancer surpasses heart disease as leading cause of death for all but the very elderly. J Natl Cancer Inst 97:330–331PubMed
5.
go back to reference Belpomme D, Irigaray P, Sasco AJ, Newby JA, Howard V, Clapp R, Hardell L (2007) The growing incidence of cancer: role of lifestyle and screening detection (review). Int J Oncol 30:1037–1049PubMed Belpomme D, Irigaray P, Sasco AJ, Newby JA, Howard V, Clapp R, Hardell L (2007) The growing incidence of cancer: role of lifestyle and screening detection (review). Int J Oncol 30:1037–1049PubMed
6.
go back to reference Belpomme D, Irigaray P, Hardell L, Clapp R, Montagnier L, Epstein S, Sasco AJ (2007) The multitude and diversity of environmental carcinogens. Environ Res 105:414–429PubMedCrossRef Belpomme D, Irigaray P, Hardell L, Clapp R, Montagnier L, Epstein S, Sasco AJ (2007) The multitude and diversity of environmental carcinogens. Environ Res 105:414–429PubMedCrossRef
7.
go back to reference Irigaray P, Newby JA, Clapp R, Hardell L, Howard V, Montagnier L, Epstein S, Belpomme D (2007) Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 61:640–658PubMedCrossRef Irigaray P, Newby JA, Clapp R, Hardell L, Howard V, Montagnier L, Epstein S, Belpomme D (2007) Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 61:640–658PubMedCrossRef
8.
go back to reference Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Brahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens--Part B: biological agents. Lancet Oncol 10:321–322PubMedCrossRef Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Brahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens--Part B: biological agents. Lancet Oncol 10:321–322PubMedCrossRef
9.
go back to reference Geller AC, Prout MN, Miller DR, Siegel B, Sun T, Ockene J, Koh HK (2002) Evaluation of a cancer prevention and detection curriculum for medical students. Prev Med 35:78–86PubMedCrossRef Geller AC, Prout MN, Miller DR, Siegel B, Sun T, Ockene J, Koh HK (2002) Evaluation of a cancer prevention and detection curriculum for medical students. Prev Med 35:78–86PubMedCrossRef
14.
go back to reference Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97:72–81PubMedCrossRef Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97:72–81PubMedCrossRef
15.
go back to reference Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, Forman D (2010) Fifty years of cancer incidence: CI5 I-IX. Int. J, Cancer Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, Forman D (2010) Fifty years of cancer incidence: CI5 I-IX. Int. J, Cancer
16.
go back to reference Soliman AS, Mullan PB, Chamberlain RM (2010) Research training of students in minority and international settings: lessons learned from cancer epidemiology education in special populations. J Cancer Educ 25:263–269PubMedCrossRef Soliman AS, Mullan PB, Chamberlain RM (2010) Research training of students in minority and international settings: lessons learned from cancer epidemiology education in special populations. J Cancer Educ 25:263–269PubMedCrossRef
17.
go back to reference Geller AC, Prout MN, Sun T, Krane R, Schroy PC, III Demierre MF, Benjes LS, Bd-El-Baki J, Mozden P, Koh HK, Stanfield L (2000) Cancer skills laboratories for medical students: a promising approach for cancer education. J Cancer Educ 15:196–199PubMed Geller AC, Prout MN, Sun T, Krane R, Schroy PC, III Demierre MF, Benjes LS, Bd-El-Baki J, Mozden P, Koh HK, Stanfield L (2000) Cancer skills laboratories for medical students: a promising approach for cancer education. J Cancer Educ 15:196–199PubMed
18.
go back to reference Chen W, Jiang Z, Shao Z, Sun Q, Shen K (2009) An economic evaluation of adjuvant trastuzumab therapy in HER2-positive early breast cancer. Value Health 12(Suppl 3):S82–S84PubMedCrossRef Chen W, Jiang Z, Shao Z, Sun Q, Shen K (2009) An economic evaluation of adjuvant trastuzumab therapy in HER2-positive early breast cancer. Value Health 12(Suppl 3):S82–S84PubMedCrossRef
19.
go back to reference Meropol NJ, Schulman KA (2007) Cost of cancer care: issues and implications. J Clin Oncol 25:180–186PubMedCrossRef Meropol NJ, Schulman KA (2007) Cost of cancer care: issues and implications. J Clin Oncol 25:180–186PubMedCrossRef
Metadata
Title
The State of Cancer Epidemiology Curricula in Postgraduate Schools Worldwide
Authors
Alireza Mosavi-Jarrahi
Ezanollah Azargashb
Yasaman Mousavi-Jarrahi
Mohammad Ali Mohagheghi
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 3/2011
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-011-0246-7

Other articles of this Issue 3/2011

Journal of Cancer Education 3/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine